Comparative Efficacy and Safety of Resmetirom Versus Semaglutide in Treating MASH and MASLD: A Network Meta-Analysis.

Autor: Ayesh H; Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.

Publikováno v: American journal of therapeutics [Am J Ther] 2024 Sep 19. Date of Electronic Publication: 2024 Sep 19.

Comparative efficacy and safety of weekly tirzepatide versus weekly insulin in type 2 diabetes: A network meta-analysis of randomized clinical trials.

Autor: Ayesh H; Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Centre, Nashville, Tennessee, USA., Suhail S; Gene Medical Laboratories, Gaza, Palestine., Ayesh S; Gene Medical Laboratories, Gaza, Palestine., Niswender K; Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Centre, Nashville, Tennessee, USA.

Publikováno v: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Sep; Vol. 26 (9), pp. 3801-3809. Date of Electronic Publication: 2024 Jun 25.

Comparative Analysis of Resmetirom vs. FGF21 Analogs vs. GLP-1 Agonists in MASLD and MASH: Network Meta-Analysis of Clinical Trials.

Autor: Ayesh H; Deaconess Health System, Evansville, IN 47708, USA., Beran A; Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN 46202, USA., Suhail S; Gene Medical Labs, Gaza 00972, Palestine., Ayesh S; Gene Medical Labs, Gaza 00972, Palestine., Niswender K; Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Publikováno v: Biomedicines [Biomedicines] 2024 Oct 14; Vol. 12 (10). Date of Electronic Publication: 2024 Oct 14.

Mazdutide Versus Dulaglutide for Weight Loss and Diabetes Management: Meta-Analysis of Randomized Clinical Trials.

Autor: Ayesh H; Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, TN., Ayesh S; Gene Medical Labs, Gaza, Palestine., Niswender K; Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, TN.

Publikováno v: American journal of therapeutics [Am J Ther] 2024 Sep-Oct 01; Vol. 31 (5), pp. e619-e622.

Comparative Meta-Analysis of Retatrutide Versus Placebo and Dulaglutide for Weight Loss and Diabetes Management: Insights From Clinical Trials.

Autor: Ayesh H; Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Ayesh S; Gene Medical Labs, Gaza, Palestine., Niswender K; Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.

Publikováno v: American journal of therapeutics [Am J Ther] 2024 Jul-Aug 01; Vol. 31 (4), pp. e523-e527.